Literature DB >> 32745367

Retzius-sparing robot-assisted radical prostatectomy: early learning curve experience in three continents.

Antonio Galfano1, Silvia Secco1, Paolo Dell'Oglio1, Koon Rha2, Christopher Eden3, Karen Fransis4, Prasanna Sooriakumaran5, Pedro Sanchez De La Muela6, Keith Kowalczyk7, Tomoaki Miyagawa8, Christophe Assenmacher9, Akio Matsubara10, Kun-Yuan Chiu11, Ugur Boylu12, Harry Lee7, Aldo Massimo Bocciardi1.   

Abstract

OBJECTIVE: To assess the effect of surgical experience on peri-operative, functional and oncological outcomes during the first 50 Retzius-sparing robot-assisted radical prostatectomy (RsRARP) cases performed by surgeons naïve to this novel approach.
MATERIALS AND METHODS: We retrospectively evaluated the initial cases operated by 14 surgeons in 12 different international centres. Pre-, peri- and postoperative features of the first 50 patients operated by each surgeon in all the participating centres were collected. The effect of surgical experience on peri-operative, functional and oncological outcomes was firstly evaluated after stratification by level of surgical experience (initial [≤25 cases] and expert [>25 cases]) and after using locally weighted scatterplot smoothing to graphically explore the relationship between surgical experience and the outcomes of interest.
RESULTS: We evaluated 626 patients. The median follow-up was 13 months in the initial group and 9 months in the expert group (P = 0.002). Preoperative features overlapped between the two groups. Shorter console time (140 vs 120 min; P = 0.001) and a trend towards lower complications rates (13 vs 5.5%; P = 0.038) were observed in the expert group. The relationship between surgical experience and console time, immediate urinary continence recovery and Clavien-Dindo grade ≥2 complications was linear, without reaching a plateau, after 50 cases. Conversely, a non-linear relationship was observed between surgical experience and positive surgical margins (PSMs).
CONCLUSIONS: In this first report of a multicentre experience of RsRARP during the learning curve, we found that console time, immediate urinary continence recovery and postoperative complications are optimal from the beginning and further quickly improve during the learning process, while PSM rates did not clearly improve over the first 50 cases.
© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #ProstateCancer; #uroonc; Retzius-sparing; learning curve; multi-centric; robot-assisted radical prostatectomy

Year:  2020        PMID: 32745367     DOI: 10.1111/bju.15196

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  4 in total

1.  Retzius-sparing RARP: improving functional outcomes.

Authors:  Antonio Galfano; Aldo Massimo Bocciardi
Journal:  Nat Rev Urol       Date:  2021-02       Impact factor: 14.432

2.  Retzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy.

Authors:  Hassan Kadhim; Kar Mun Ang; Wei Shen Tan; Arjun Nathan; Nicola Pavan; Giorgio Mazzon; Omar Al-Kadhi; Gu Di; Eoin Dinneen; Tim Briggs; Anand Kelkar; Prabhakar Rajan; Senthil Nathan; John D Kelly; Prasanna Sooriakumaran; Ashwin Sridhar
Journal:  J Robot Surg       Date:  2022-02-22

3.  Challenging cases in high-risk prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy.

Authors:  Stefano Tappero; Paolo Dell'Oglio; Mattia Longoni; Carlo Buratto; Erika Palagonia; Pietro Scilipoti; Enrico Vecchio; Marco Martiriggiano; Silvia Secco; Alberto Olivero; Michele Barbieri; Giancarlo Napoli; Elena Strada; Giovanni Petralia; Dario Di Trapani; Aldo Massimo Bocciardi; Antonio Galfano
Journal:  World J Urol       Date:  2022-06-30       Impact factor: 3.661

4.  A Combined Technology to Protect the Anatomic Integrity of Distal Urethral Sphincter Complex in Radical Prostatectomy Improves Early Urinary Continence Recovery Without Sacrifice of Oncological Outcomes.

Authors:  Ao Liu; Yi Gao; Hai Huang; Xiaoqun Yang; Wenhao Lin; Lu Chen; Danfeng Xu
Journal:  Front Oncol       Date:  2021-08-05       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.